2-Bromo-6-chloro-9-(2,3,5-tri-O-acetyl-β-D-ribofuranosyl)-9H-purine structure
|
Common Name | 2-Bromo-6-chloro-9-(2,3,5-tri-O-acetyl-β-D-ribofuranosyl)-9H-purine | ||
|---|---|---|---|---|
| CAS Number | 40896-58-0 | Molecular Weight | 491.68 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C16H16BrClN4O7 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of 2-Bromo-6-chloro-9-(2,3,5-tri-O-acetyl-β-D-ribofuranosyl)-9H-purine2-Bromo-6-chloro-9-(2,3,5-tri-O-acetyl-β-D-ribofuranosyl)-9H-purine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1]. |
| Name | m-Tolyl-p-acetylphenyldisulfid |
|---|
| Description | 2-Bromo-6-chloro-9-(2,3,5-tri-O-acetyl-β-D-ribofuranosyl)-9H-purine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1]. |
|---|---|
| Related Catalog | |
| References |
| Molecular Formula | C16H16BrClN4O7 |
|---|---|
| Molecular Weight | 491.68 |
| Exact Mass | 247.04900 |
| PSA | 76.62000 |
| LogP | 4.95780 |
| InChIKey | FALQPDDXFMGVNW-SDBHATRESA-N |
| SMILES | CC(=O)OCC1OC(n2cnc3c(Cl)nc(Br)nc32)C(OC(C)=O)C1OC(C)=O |